Centrica plc (LON:CNA - Get Free Report) insider Chris OShea acquired 427 shares of the stock in a transaction dated Thursday, June 5th. The shares were bought at an average cost of GBX 161 ($2.18) per share, for a total transaction of £687.47 ($931.66).
Centrica Price Performance
LON:CNA remained flat at GBX 160.70 ($2.18) on Monday. The company's stock had a trading volume of 21,546,807 shares, compared to its average volume of 27,935,613. The company has a debt-to-equity ratio of 66.48, a quick ratio of 0.40 and a current ratio of 1.77. Centrica plc has a twelve month low of GBX 112.99 ($1.53) and a twelve month high of GBX 165.25 ($2.24). The stock's 50 day moving average is GBX 152.63 and its 200-day moving average is GBX 142.70. The stock has a market capitalization of £8.03 billion, a price-to-earnings ratio of 7.66, a PEG ratio of 0.45 and a beta of 1.08.
Centrica Company Profile
(
Get Free Report)
Centrica is energising a greener, fairer future for our colleagues, customers and communities. Our integrated business operates across the energy value chain, with over ten million Retail customers, leading brands such as British Gas and Bord Gáis Energy, and the UK's largest energy services workforce.
Recommended Stories

Before you consider Centrica, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Centrica wasn't on the list.
While Centrica currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.
Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.